ML18129A029

Transmittal Letter for Final Safety Evaluation for Topical Report ANP-10340P, Revision 0, Incorporation of Chromia-Doped Fuel Properties in Areva Approved Methods (CAC No. MF7707; EPID L-2016-TOP-0004)

ML18129A029
Person / Time
Site:	PROJ0728, 99902041
Issue date:	05/23/2018
From:	Dennis Morey NRC/NRR/DLP/PLPB
To:	Peters G Framatome
Rowley J
Shared Package
ML18129A020	List: ML18129A025 ML18129A029 ML18144A951
References
CAC MF7707, EPID L-2016-TOP-0004
Download: ML18129A029 (3)

Text

OFFICIAL USE ONLY-PROPRIETARY INFORMATION May 23, 2018 Mr. Gary Peters, Director Licensing and Regulatory Affairs Framatome Inc.

3315 Old Forest Road Lynchburg, VA 24501

SUBJECT:

FINAL SAFETY EVALUATION FOR FRAMATOME INC. TOPICAL REPORT ANP-10340P, REVISION 0, INCORPORATION OF CHROMIA-DOPED FUEL PROPERTIES IN AREVA APPROVED METHODS (CAC NO. MF7707; EPID L-2016-TOP-0004)

Dear Mr. Peters:

By letter dated April 29 2016 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML16124B091), Framatome, Inc. (Framatome, formerly AREVA, Inc.)

submitted Topical Report (TR) ANP-10340P, Revision 0, Incorporation of Chromia-Doped Fuel Properties in AREVA Approved Methods, to the U.S. Nuclear Regulatory Commission (NRC) staff for review and approval. By letter dated April 26, 2018 (ADAMS Accession No. ML18100B020), an NRC draft safety evaluation (SE) regarding our approval of TR ANP-10340P, Revision 0, was provided for your review and comment. By letter dated May 1, 2018 (ADAMS Accession No. ML18123A355), Framatome provided comments on the draft SE. The NRC staffs disposition of the Framatome comments on the draft SE are discussed in the attachment (ADAMS Accession No. ML18129A025) to the final SE enclosed with this letter.

The NRC staff has found that TR ANP-10340P, Revision 0, is acceptable for referencing in licensing applications for nuclear power plants to the extent specified and under the limitations and conditions delineated in the TR and in the enclosed final SE. The final SE defines the basis for our acceptance of the TR.

Our acceptance applies only to material provided in the subject TR. We do not intend to repeat our review of the acceptable material described in the TR. When the TR appears as a reference in licensing action requests, our review will ensure that the material presented applies to the specific plant involved. Requests for licensing actions that deviate from this TR will be subject to a plant-specific review in accordance with applicable review standards.

Notice: The enclosure transmitted herewith contains Proprietary Information.

When separated from the enclosure, this transmittal document is decontrolled.

OFFICIAL USE ONLY-PROPRIETARY INFORMATION

OFFICIAL USE ONLY-PROPRIETARY INFORMATION G. Peters In accordance with the guidance provided on the NRC website, we request that Framatome publish approved proprietary and non-proprietary versions of TR ANP-10340P, Revision 0, within 3 months of receipt of this letter. The approved versions shall incorporate this letter and the enclosed final SE after the title page. Also, they must contain historical review information, including NRC requests for additional information and your responses. The approved versions shall include an -A (designating approved) following the TR identification symbol.

As an alternative to including the RAIs and RAI responses behind the title page, if changes to the TR were provided to the NRC staff to support the resolution of RAI responses, and if the NRC staff reviewed and approved those changes as described in the RAI responses, there are two ways that the accepted version can capture the RAIs:

1. The RAIs and RAI responses can be included as an Appendix to the accepted version.

2. The RAIs and RAI responses can be captured in the form of a table (inserted after the final SE) which summarizes the changes as shown in the approved version of the TR.

The table should reference the specific RAIs and RAI responses which resulted in any changes, as shown in the accepted version of the TR.

If future changes to the NRCs regulatory requirements affect the acceptability of this TR, Framatome will be expected to revise the TR appropriately or justify its continued applicability for subsequent referencing. Licensees referencing this TR would be expected to justify its continued applicability or evaluate their plant using the revised TR.

Sincerely,

/RA/

Dennis C. Morey, Chief Licensing Processes Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Project No. 728 Docket No. 99902041

Enclosure:

Final Safety Evaluation (Proprietary)

OFFICIAL USE ONLY-PROPRIETARY INFORMATION

Package ML18129A020 Letter ML18129A029 Proprietary SE ML18129A023 (Attachment)

Nonproprietary SE ML18129A025 *concurrence via email NRR-106 OFFICE NRR/DLP/PLPB NRR/DLP/PLPB* NRR/DSS/SNPB NRR/DLP/PLPB NAME JRowley DHarrison RLukes DMorey DATE 05/09/18 05/15/18 05/18/18 05/23/18